Oramed Pharma (ORMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 0 | 0 | 0 | 2,000 | 0 |
| Cost of Goods | N/A | N/A | N/A | 1,987 | N/A |
| Gross Profit | N/A | N/A | N/A | 13 | N/A |
| Operating Expenses | 5,672 | 2,427 | 2,489 | 5,500 | 3,595 |
| Operating Income | -5,672 | -2,427 | -2,489 | -4,500 | -3,595 |
| Other Income | 15,469 | 61,878 | 15,623 | -2,558 | -6,188 |
| Pre-tax Income | 9,797 | 59,451 | 13,134 | -7,058 | -9,783 |
| Income Tax | -212 | 11,062 | -126 | 584 | 416 |
| Net Income Continuous | 10,009 | 48,389 | 13,260 | -7,642 | -10,199 |
| Minority Interests | N/A | -6 | -28 | N/A | -10 |
| Net Income | $10,009 | $48,395 | $13,288 | $-7,642 | $-10,189 |
| EPS Basic Total Ops | 0.24 | 1.16 | 0.32 | -0.19 | -0.26 |
| EPS Basic Continuous Ops | 0.26 | 1.16 | 0.32 | -0.19 | -0.25 |
| EPS Diluted Total Ops | 0.15 | 1.13 | 0.31 | -0.19 | -0.26 |
| EPS Diluted Continuous Ops | 0.25 | 1.13 | 0.31 | -0.19 | -0.25 |
| EPS Diluted Before Non-Recurring Items | -0.06 | 0.00 | -0.05 | -0.19 | 0.01 |
| EBITDA(a) | $-5,642 | $-2,396 | $-2,459 | $-4,470 | $-3,564 |